Comparative Degenerative Liver with Amalar, Chloroquine, Cotecxin and Fansidar

نویسنده

  • E. O. JIMMY
چکیده

A comparative histologic effects of chloroquine, fansidar, amalar and cotecxin on the liver was carried out on thirty (30) male and female albino rats for the period of twenty eight days (28) days. The liver with chloroquine administration showed congestion of the central veins and the pericentral hepacytes had mild degeneration as against the control group without the drug. However, in the fansidar drug group there was no dilation of the pericentral hepatocytes nor congestion and degenerative changes though the central veins were dilated. But the liver with cotecxin administration showed veinous dilation, congestion and infiltration of inflammatory cells into the central veins not seen in the control group. On the other hand, the liver’s reaction to amalar drug only resulted in mild congestion of the central veins. It is shown in the study that cotecxin and chloroquine curative antimalarials continuous intake may cause liver cirrhosis. Copyright © WJMMS, all rights reserved.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Comparative Evaluation of Gastric and Blood Anomalies in Coartem, Chloroquine, Fansidar and Linart and in Experimental Malaria

Study on the effects of some antimalaria drugs; coartem, fansidar and lonart on gastric acid secretion was carried out for 14 days on thirty albino male and female mice infected with Plasmodium berghei berghei malaria parasite. The results showed that coartem at a dosage of 33.6mg/kg decreased red blood cells count as compared with control P<0.05, same with chloroquine at a dosage of 14.3mg/kg....

متن کامل

Tolerability of long-term prophylaxis with fansidar: a randomized double-blind study in Nigeria.

A randomized double-blind study was performed to compare the side effects of long-term chemoprophylaxis of malaria with Fansidar (1 tablet a week) with those of a 300-mg weekly chloroquine regimen. This study was designed as a field trial with Austrian industrial workers in Nigeria and included 173 volunteers, 86 taking Fansidar and 87 taking chloroquine for 6 to 22 months. Only a few complaint...

متن کامل

Cytogenetic evaluation of Fansidar on human lymphocyte chromosomes in vitro.

Fansidar is a fixed combination of two antimalarial agents a diaminopyrimidine (Pyrimethamine) and a sulphonamide (Sulphadoxine) in the ratio 1:20- that have been used extensively worldwide for the treatment of Chloroquine resistant Plasmodium falciparum malaria, toxoplasmosis and Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. This study examined the eff...

متن کامل

Erythema multiforme (Stevens-Johnson) precipitated by Fansidar.

The combination of pyrimethamine and suiphonamide is effective prophylaxis against Plasmo&dm falciparum malaria (Lucas et al., 1969) and is specifically recommended for use in areas where chloroquine-resistant malaria is encountered such as Kenya (British National Formulary, 1983). The sulphonamide component of Fansidar is sulfadoxine, and we believe it is this sulphonamide which precipitated t...

متن کامل

Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda.

BACKGROUND A pre-packaged fixed-dose formulation of chloroquine (CQ) and sulfadoxine/pyrimethamine (S/P) combination (Homapak) is widely used for the treatment of falciparum malaria in Ugandan children. It is however a product whose pharmacokinetics and interactions have not been studied. OBJECTIVES To explore possible pharmacokinetic interactions between CQ and S/P during co-administration, ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014